


Healthcare News Roundup: HIV/AIDS
HSMN NewsFeed - 20 Sep 2007
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
HSMN NewsFeed - 17 Sep 2007
Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
